They think they will be the cheapest and the best, the Gold Standard, predictive v diagnostic and more expensive for the others, so a money saving test for Health Systems with better outcomes for patients.
Soft launch this year, Hard launch after Jan 1st 2024 when reimbursement kicks in.
World wide there are 450 million sufferers of diabetes, he couldn't really comment on how many tests they'd sell in the US because that is Sonics business. Sonic are dealing with the payors so really ticking a big box there because they already have those systems in place.
They feel Reimbursement is the most important step they've ever made and the size of the reimbursement is much larger then they were expecting but it is still considered a cheap test in the US who generally provide the largest reimbursements of any Health Systems. Didn't sound too concerned about Australia and TGA, USA is their main market.
Really a very promising set up imo
PIQ Price at posting:
$1.13 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)